Skip to content
Frank UreñaMD Candidate | Physician-Scientist

PhD Physician-Scientist · Harvard & MGH-Trained · MD Candidate

MD Candidate | Physician-Scientist

Translating immunology into medicine that reaches patients.

Harvard- and MGH-trained physician-scientist with a PhD in immunology, 113 citations across four peer-reviewed papers — including Nature Biomedical Engineering and first-author work in the Journal of Biological Chemistry.

10+ years in biomedical research

4 peer-reviewed articles

113 citations

Training and research environments

SGU - St. George's UniversityHMS - Harvard Medical SchoolMGH - Massachusetts General HospitalWyss - Wyss InstituteUH - University of Hawaiʻi at MānoaNHS/NNUH - Norfolk & Norwich University Hospital
Frank Ureña, physician-scientist

Mission

Translational research with direct clinical relevance.

Current focus

Targeting academic internal medicine and oncology — with a PSTP focus.

Open to IM/oncology residency programs, PSTP inquiries, research collaborators, and physician-scientist mentors.

Research Focus

Research pillars built for translational impact.

Each focus area is tied to the same standard: the work should help explain disease more clearly and move biomedical insight closer to better patient care.

Positioning

General physician-scientist profile with a research identity rooted in immunology, translational systems, and clinical relevance.

Translational Medicine

Bridging mechanistic discovery in the lab to questions that can improve diagnosis, therapy, and patient outcomes.

The strongest biomedical research earns its value when it changes what clinicians can measure, explain, or offer at the bedside.

Immunology and Molecular Systems

Studying immune signaling, microRNA regulation, and cellular decision-making across complex disease states.

Understanding how cells switch between activation, tolerance, and dysfunction helps reveal where intervention can be most effective.

Oncology and Clinical Integration

Applying medical training to cancer and immune-mediated disease — targeting academic internal medicine with an oncology focus where clinical and scientific work inform each other.

Clinical context sharpens scientific judgment. An oncology-focused physician-scientist can ask the questions that actually matter to patients with cancer and immune disease.

Innovation and Future Medicine

Building platform thinking through diagnostics, biomaterials, organoids, and systems-based approaches to disease.

Future-facing medicine will depend on tools that connect biological complexity to faster, smarter decisions in care and research.

Current Work

What I am building right now.

My present work is about connecting clinical training, translational judgment, and long-term academic direction so each next step strengthens the full physician-scientist platform.

Right now

Open to academic internal medicine and oncology residency inquiries, PSTP programs, research collaboration, and physician-scientist mentorship.

Current priority

Integrating clinical training with translational thinking

Building bedside perspective through medical education while staying focused on the long-term role of physician-scientist leadership.

Current priority

Targeting academic internal medicine and oncology residency programs

Pursuing academic internal medicine programs — ideally with a medical oncology or cancer immunology track and a dedicated Physician-Scientist Training Program (PSTP) — where clinical excellence and translational discovery reinforce each other.

Current priority

Advancing a research identity rooted in immune biology

Carrying forward prior work in immunology, molecular systems, and translational platforms toward future clinically meaningful investigations.

Selected Publications

Authority built on peer-reviewed work.

Representative publications in translational immunology, molecular signaling, and platform-oriented biomedical research.

Nature Biomed EngNature Portfolio202275 citations

Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock.

Demonstrated that immune-instructive biomaterials can capture bacterial signals in vivo and generate protection against sepsis, highlighting a path from materials engineering to clinically relevant infection control.

Super M, Doherty E, Cartwright M, Ureña FR, et al. · Nature Biomedical Engineering · 10.1038/s41551-021-00756-3

View article
J Biol ChemTop Journal202214 citations

T-cell activation decreases miRNA-15a/16 levels to promote MEK1-ERK1/2-Elk1 signaling and proliferative capacity.

Showed that activation-driven loss of miR-15a/16 releases the MEK1-ERK-Elk1 pathway and expands T-cell proliferative capacity, clarifying a tractable lever in immune regulation.

Ureña FR, Ma C, Hoffmann FW, et al. · Journal of Biological Chemistry · 10.1016/j.jbc.2022.101639

View article
J Leukoc BiolTop Journal202212 citations

Selenoprotein I deficiency in T cells promotes differentiation into tolerant phenotypes while decreasing Th17 pathology.

Defined selenoprotein I as a regulator of T-cell fate, linking metabolic control to tolerant versus inflammatory immune phenotypes in ways that matter for immune-mediated disease.

Ma C, Hoffmann FW, Nunes LGA, Ureña FR, et al. · Journal of Leukocyte Biology · 10.1002/JLB.1A0122-080R

View article
Sci RepPeer-Reviewed202212 citations

Loop-mediated isothermal amplification (LAMP) assay for specific and rapid detection of Dickeya fangzhongdai targeting a unique genomic region.

Built a rapid molecular diagnostic assay for field detection, reflecting a broader interest in translational platforms that shorten the distance between measurement and action.

DeLude A, Wells R, Boomla S, Chuang SC, Ureña FR, et al. · Scientific Reports · 10.1038/s41598-022-22023-4

View article

Experience

A training story shaped by translational work.

This is not just a record of roles. It is the sequence that built a durable physician-scientist identity across pathology, preclinical systems, doctoral research, postdoctoral work, and medicine.

Current training

MD Candidate

St. George's University School of Medicine

2023 - Present

UK, Grenada, and U.S. clinical rotations

Clinical training that keeps future research grounded in real patient questions, real workflows, and real outcome gaps.

  • Integrating core rotations across internal medicine, surgery, and subspecialties with a long-term physician-scientist trajectory.
  • Using clinical exposure to identify the disease questions most worth translating back to the laboratory.

Postdoctoral training

Postdoctoral Research Fellow

Harvard Medical School / Massachusetts General Hospital

2022 - 2023

Boston, MA

Extended translational training into cancer biology, tumor immunology, organoid systems, and the immune microenvironment — work that directly informs a long-term research agenda in oncology.

  • Studied cancer-associated fibroblasts in pancreatic ductal adenocarcinoma (PDAC) and immune cell integration in alveolar type 2 organoid models at Harvard Medical School and MGH.
  • Expanded fluency in patient-derived organoids, single-cell approaches, and tumor-immune interface biology — building the translational oncology foundation for a physician-scientist career.

Doctoral research

Graduate Research Assistant and PhD Researcher

John A. Burns School of Medicine, University of Hawaiʻi

2019 - 2023

Honolulu, HI

Built a mechanistic immunology program around microRNA control of T-cell proliferation and signaling.

  • Designed and executed studies defining miR-15a/16 regulation of the MEK1-ERK1/2-Elk1 axis in T-cell activation.
  • Graduated with a PhD in Molecular Biosciences and Bioengineering after connecting molecular insight to broader translational relevance in immune modulation.

Foundational work

Scientific Assistant

Washington State University Gene Editing Core

2019

Pullman, WA

Supported gene-editing workflows that turned experimental questions into tractable biological models.

  • Designed CRISPR guide RNAs and supported knockout and knock-in model generation pipelines.
  • Contributed to validation and genotyping workflows that improved experimental readiness for downstream studies.

Approach to Medicine and Research

Science, data, and medicine should sharpen each other.

I view medicine as a system that extends beyond individual patient encounters — one that needs physicians who also generate and evaluate the evidence. The patients I most want to help are the ones whose diseases we still understand poorly, and whose best treatments have not yet been discovered.

My goal is to be that physician: one who treats disease today and produces the science that changes how it is treated tomorrow.

Contact

Open to research collaboration and academic opportunities.

Whether you are reaching out about residency fit, translational research, mentorship, or academic collaboration, this site is built to make the next conversation easy.

Preferred contact

Please use the contact form for all inquiries, including residency outreach, research collaboration, mentorship, and academic opportunities.

Contact form only

This site uses cookies.

Essential cookies remember your cookie preference. Analytics cookies stay off until you accept all cookies. Visit the cookies policy page for more information about consent mode and to change your preference later.

Analytics cookies stay off until you choose otherwise.